4 Midcap 10-25 Per Cent Below 52-Week High Stocks to Watch for Future Multibagger Potential: Oil India, Phoenix Mills, Mphasis and Ajanta Pharma
- October 28, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Oil India Rs 457.35. Phoenix Mills Rs 1,905. Mphasis Rs 2,618.40. Ajanta Pharma Rs 3,353.60. Market caps from Rs 42,214 crore to Rs 72,822 crore. Data as of 27 Oct 2026.
Quick Answer
Oil India, Phoenix Mills, Mphasis and Ajanta Pharma are the 4 picks in this 10-25 per cent below 52-week high stocks watchlist, with market caps between Rs 42,214 crore and Rs 72,822 crore. Oil India stands out for the strongest latest-quarter profit growth at 96.77%, while Phoenix Mills offers the fastest profit growth, 58.28% a year since FY22. PE ratios run from 7.64 to 42.32, so compare each one with its industry PE before investing. All figures are as of 27 October 2026.
10-25 per cent below 52-week high stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Oil India, Phoenix Mills, Mphasis and Ajanta Pharma meet that test, with market caps from Rs 42,214 crore to Rs 72,822 crore and Oil India offering the strongest latest-quarter profit growth at 96.77%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price 10 to 25 per cent below its 52-week high, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price 10 to 25 per cent below its 52-week high, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening 10-25 per cent below 52-week high stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are 10-25 Per Cent Below 52-Week High Stocks and Why Do They Attract Multibagger Interest?
10-25 per cent below 52-week high stocks are shares that trade a moderate distance under their yearly peak, which leaves room to climb back toward the high if results stay strong. The four here cover malls and real estate, oil and gas, IT services and pharmaceuticals.
A pullback of this size in a business with growing profit gives investors a better entry point than the peak, without the deep fall that signals trouble. For 10-25 per cent below 52-week high stocks, both FY26 and the latest quarter showed growth. Whichever way you read 10-25 per cent below 52-week high stocks, the common thread is rising profit backed by complete financial data. With 10-25 per cent below 52-week high stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for 10-25 per cent below 52-week high stocks are complete. Read each company’s latest results and exchange filings before acting on 10-25 per cent below 52-week high stocks.
10-25 Per Cent Below 52-Week High Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 27 October 2026. Oil India has the lowest PE of the group at 7.64, while Ajanta Pharma posts the highest return on equity at 23.33%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Oil India | 457.35 | 72,822 | 7.64 | 7.16 | 11.41% | 0.65 | 395.60 to 531.00 |
| Phoenix Mills | 1,905 | 68,990 | 42.32 | 31.56 | 11.14% | 0.48 | 1,465.60 to 2,169.80 |
| Mphasis | 2,618.40 | 49,108 | 25.71 | 18.49 | 17.34% | 0.24 | 2,013.00 to 2,975.00 |
| Ajanta Pharma | 3,353.60 | 42,214 | 37.20 | 36.35 | 23.33% | 0.06 | 2,380.20 to 3,796.00 |
Oil India: Quarterly Profit Up 96.77%
Oil India is a government-owned oil and gas exploration and production company with operations in Assam, Rajasthan and overseas blocks. It reported FY26 revenue of Rs 35,877.28 crore, up 4.97% year on year, and net profit of Rs 7,550.67 crore, up 7.26%. Revenue has compounded at 7.32% a year since FY22. Operating margin was 36.43% in FY26.
In the June 2026 quarter, revenue rose 46.98% to Rs 13,236.10 crore and net profit grew 96.77% to Rs 4,026.83 crore. The share price has gained 183.64% over five years. Domestic institutions raised their holding from 18.41% in June 2025 to 20.14% in June 2026. The stock trades at a PE of 7.64 against an industry PE of 7.16. The dividend yield is 2.57%.
Phoenix Mills: 58.28% Profit CAGR Since FY22
Phoenix Mills owns and runs large retail malls across India under the Phoenix Marketcity and Palladium brands, along with offices, hotels and residences. It reported FY26 revenue of Rs 4,593.55 crore, up 15.87% year on year, and net profit of Rs 1,556.61 crore, up 19.60%. Net profit has compounded at 58.28% a year since FY22, while revenue has grown 31.04% a year. Operating margin was 62.83% in FY26. The debt-to-equity ratio is 0.48.
The stock trades at a PE of 42.32 against an industry PE of 31.56. In the June 2026 quarter, revenue rose 13.27% to Rs 1,115.15 crore and net profit grew 23.02% to Rs 393.55 crore. The share price has gained 303.49% over five years and 11.92% over the past year. Domestic institutions raised their holding from 15.47% in September 2025 to 17.31% in September 2026.
Mphasis: Profit Compounding at 6.81% a Year
Mphasis provides IT, cloud and application services to banking, insurance and technology clients. It reported FY26 revenue of Rs 16,205.54 crore, up 11.88% year on year, and net profit of Rs 1,862.60 crore, up 9.43%. Net profit has compounded at 6.81% a year since FY22, while revenue has grown 7.53% a year. Operating margin was 20.58% in FY26. The debt-to-equity ratio is 0.24.
In the June 2026 quarter, revenue rose 17.14% to Rs 4,466.91 crore and net profit grew 10.82% to Rs 489.51 crore. Domestic institutions raised their holding from 37.07% in September 2025 to 45.85% in September 2026. The stock trades at a PE of 25.71 against an industry PE of 18.49, with a return on equity of 17.34%. The dividend yield is 2.41%.
Ajanta Pharma: Return on Equity of 23.33%
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 37.20 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.
10-25 Per Cent Below 52-Week High Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these 10-25 per cent below 52-week high stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Oil India | 35,877.28 | 7,550.67 | 4.97% | 7.32% | 2.96% | 49.06% |
| Phoenix Mills | 4,593.55 | 1,556.61 | 15.87% | 31.04% | 58.28% | 63.42% |
| Mphasis | 16,205.54 | 1,862.60 | 11.88% | 7.53% | 6.81% | 20.04% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 10.33% | 30.41% |
Check the Univest Screener for live data on these 10-25 per cent below 52-week high stocks
Institutional Holding in Oil India, Phoenix Mills, Mphasis and Ajanta Pharma
Institutional holding shows who is backing these 10-25 per cent below 52-week high stocks alongside the promoter. The table uses the latest reported quarter for each. Mphasis has the deepest institutional backing, with FII and DII together holding 65.24% as of September 2026. Domestic institutions increased their holding over the past year in Oil India (from 18.41% to 20.14%), Phoenix Mills (from 15.47% to 17.31%), Mphasis (from 37.07% to 45.85%) and Ajanta Pharma (from 17.90% to 21.94%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Oil India | 56.66% | 7.28% | 20.14% | 15.93% | June 2026 |
| Phoenix Mills | 47.24% | 31.62% | 17.31% | 3.83% | September 2026 |
| Mphasis | 30.53% | 19.39% | 45.85% | 4.23% | September 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in 10-25 Per Cent Below 52-Week High Stocks
Being careful with 10-25 per cent below 52-week high stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between 10-25 Per Cent Below 52-Week High Stocks
Picking from 10-25 per cent below 52-week high stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (7.16 to 36.35) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Oil India, Phoenix Mills, Mphasis and Ajanta Pharma live prices.
Conclusion
Among 10-25 per cent below 52-week high stocks, Oil India stands out for the strongest latest-quarter profit growth at 96.77%, Phoenix Mills for the fastest profit growth, 58.28% a year since FY22, Mphasis for 11.88% revenue growth in FY26 and Ajanta Pharma for the highest return on equity at 23.33%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing 10-25 per cent below 52-week high stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on 10-25 Per Cent Below 52-Week High Stocks to Watch
Which are the best 10-25 per cent below 52-week high stocks to watch for multibagger potential?
Ans. Oil India, Phoenix Mills, Mphasis and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 72,822 crore, Rs 68,990 crore, Rs 49,108 crore and Rs 42,214 crore respectively. Oil India is notable for the strongest latest-quarter profit growth at 96.77%. Phoenix Mills stands out for the fastest profit growth, 58.28% a year since FY22. Mphasis offers 11.88% revenue growth in FY26. Ajanta Pharma brings the highest return on equity at 23.33%. These are watchlist names for 10-25 per cent below 52-week high stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Ajanta Pharma a good stock for long-term investors?
Ans. Ajanta Pharma has a return on equity of 23.33%, a PE of 37.20 against an industry PE of 36.35 and a market cap of Rs 42,214 crore. Net profit has compounded at 10.33% a year since FY22, and FY26 revenue rose 18.60% while June 2026 quarter net profit grew 30.89%. Long-term returns in 10-25 per cent below 52-week high stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Phoenix Mills become a multibagger from here?
Ans. Phoenix Mills has already gained 303.49% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in 10-25 per cent below 52-week high stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 58.28% a year since FY22, and FY26 revenue rose 15.87%. At a PE of 42.32 against an industry PE of 31.56, valuation should be checked against that growth before investing.
What is the market cap of Oil India, Phoenix Mills, Mphasis and Ajanta Pharma?
Ans. As of 27 October 2026, Oil India has a market cap of Rs 72,822 crore, Phoenix Mills has a market cap of Rs 68,990 crore, Mphasis has a market cap of Rs 49,108 crore and Ajanta Pharma has a market cap of Rs 42,214 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on 10-25 per cent below 52-week high stocks.
What are the risks of investing in 10-25 per cent below 52-week high stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings growth needs to hold up.
Why is Mphasis trading at a PE of 25.71?
Ans. Mphasis’ PE of 25.71 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 17.34% and latest-quarter profit growth of 10.82%, which also means the stock is more sensitive if growth slows. Investors in 10-25 per cent below 52-week high stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Oil India, Phoenix Mills, Mphasis and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 27.42% of Oil India (7.28% and 20.14%), 48.93% of Phoenix Mills (31.62% and 17.31%), 65.24% of Mphasis (19.39% and 45.85%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in 10-25 per cent below 52-week high stocks, though it should be read with earnings trends rather than on its own.
